Research Database
The only comprehensive database for clinical and medical research papers on the healthy benefits of matcha/green tea
Explore Research Topic
Cognitive Function
Matcha consumption leads to much higher intake of green tea phytochemicals compared to regular green tea. Previous research on caffeine, L-theanine, and epigallocatechin gallate (EGCG) repeatedly demonstrated benefits on cognitive performance.
Learn More
Heart Health
According to Harvard Medical School, “lowering your risk of cardiovascular disease may be as easy as drinking green tea. Studies suggest this light, aromatic tea may lower LDL cholesterol and triglycerides, which may be responsible for the tea's association with reduced risk of death from heart disease and stroke.”
Learn More
Mental Health
Matcha contains an amino acid called L-theanine, which has been shown to reduce physiological and psychological stresses. L-theanine also improves cognition and mood in a synergistic manner with caffeine, and promotes alpha wave production in the brain
Learn More
Cancer Prevention
Matcha/green tea has for many centuries been regarded as an essential part of good health in Japan and China. Many believe it can help reduce the risk of cancer, and a growing body of evidence backs this up.
Learn More
Immunity
A recent study in the journal Proceedings of the National Academy of Sciences concluded that drinking matcha daily greatly enhanced the overall response of the immune system. The exceedingly high levels of antioxidants in matcha mainly take the form of polyphenols, catechins, and flavonoids, each of which aids the body’s defense in its daily struggles against free radicals that come from the pollution in your air, water and foods.
Learn MoreMost Recent Research Articles
Author: Renato G. Peres and Fernando G. Tonin and Marina F.M. Tavares and Delia B. Rodriguez-Amaya
A sulfated-β-cyclodextrin (s-β-CD) modified reduced flow micellar electrokinetic chromatography (RF-MEKC) method was developed and validated for the determination of catechins in green tea. The optimal electrolyte consisted of 0.2% triethylamine, 50 mmol/L SDS and 0.8% s-β-CD (pH = 2.9), allowing baseline separation of five catechins in 4 min. The samples and standards were injected at 0.6 psi for 5 s under constant voltage of −30 kV. Sample preparation simply involved extraction of 2 g of tea with 200 mL water at 95 °C under constant stirring for 5 min. The method demonstrated excellent performance, with limits of detection (LOD) and quantification (LOQ) of 0.02–0.1 and 0.1–0.5 μg/mL, respectively, and recovery percentages of 94–101%. The method was applied to six samples of Brazilian green tea infusions. Epigallocatechin gallate (23.4–112.4 μg/mL) was the major component, followed by epigallocatechin (18.4–78.9 μg/mL), epicatechin gallate (5.6–29.6 μg/mL), epicatechin (4.6–14.5 μg/mL) and catechin (3.2–8.2 μg/mL).
Author: J.A. Macedo and V. Battestin and M.L. Ribeiro and G.A. Macedo
Green tea (Camellia sinensis) and yerba mate (Ilex paraguariensis) are rich in polyphenolic compounds, which are thought to contribute to the health benefits of tea. The aim of this study was to evaluate the potential antioxidant properties of green tea and yerba mate extracts before and after the enzymatic biotransformation reaction catalysed by the Paecilomyces variotii tannase. The antiradical properties of the tea extracts, as well as the standards of chlorogenic acid and EGCG, were assessed using the ORAC and DPPH assays before and after the tannase biotransformation. The antioxidant power of enzyme-treated green tea and yerba mate increased by 55% and 43%, respectively, compared with that of untreated teas. The antioxidant power of the standards was also highly increased by enzyme treatment. These results provide relevant data about the potential of the tannase application on various polyphenol sources and to increase the antioxidant power of two widely consumed beverages.
Author: Jacek Obuchowicz and Ulrich H. Engelhardt and Katie Donnelly
A worldwide data collection was undertaken using the validated ISO methods ISO 14502 parts 1 and 2, with 17 laboratories participating worldwide. This is the largest tea database worldwide, containing 295 black- and 358 green-origin teas. We found it quite easy to differentiate most green and black teas by the type of analysis presented in this study. The geographic spread gave a good representation of the vast majority of the producing countries. The production figures of the countries and the proportion of teas in the database are very similar. There are only a few origins which are not easy to differentiate, e.g. Darjeeling samples fall into the area of green teas. Other types of tea, e.g. Oolong or white teas, are currently not in the database. In the future other standardized methods for tea phenolics, such as theaflavins or flavonol glycosides, might become available. Additional data will certainly contribute to an even more robust discrimination between the types of tea.
Author: W.G. Pantsi and J.L. Marnewick and A.J. Esterhuyse and F. Rautenbach and J. van Rooyen
Rooibos, a unique South African herbal tea, is known to be an important source of unique polyphenolic compounds. In the present study we have quantified the main polyphenolic compounds in both fermented/traditional and unfermented/“green” rooibos (Aspalathus linearis) and evaluated its cardioprotective effects against ischaemia/reperfusion injury. Male Wistar rats consumed aqueous rooibos and green tea (Camellia sinensis) extracts (2%, w/v) for 7 weeks before their hearts were rapidly excised and perfused in a working heart perfusion apparatus. The results showed that the rooibos supplemented hearts significantly improved aortic output recovery after reperfusion when compared to the green tea supplemented hearts. Additionally, we showed that the rooibos extracts, containing the highest amount of flavonols, significantly decreased the level of cleaved caspase-3 and PARP, both pro-apoptotic proteins, during reperfusion when compared to green tea. Green tea supplementation increased phosphorylation of total PKB/Akt, Akt (threonine 308) and Akt (serine 473). The rooibos extracts did not cause significant change in the levels of the pro-survival PKB/Akt (threonine 308 and serinet 473). The GSH/GSSG ratio in the hearts of the green tea supplemented group was significantly (p < 0.05) lower when compared to RF (37.78 ± 28.63), RU (33.20 ± 4.13) and C (45.50 ± 14.96). The results clearly demonstrate the cardio-protective properties of aqueous rooibos extracts via the inhibition of apoptosis which can possibly be related to the flavonol content of this unique South African herbal tea.
Author: Congde Huo and Q. Ping Dou and Tak Hang Chan
A series of phosphate or phosphate–acetate hybrid modified EGCG or EGCG G ring deoxy analogs were synthesized by a convenient semi-synthesis strategy from the abundant natural compound EGCG.
Author: Amber Sharma and Weibiao Zhou
A green tea extract (GTE) was incorporated into biscuit as a source of tea catechins. The stability of tea catechins in the biscuit making process was studied. A method was developed for the separation and quantification of tea catechins in GTE, dough, and biscuit samples using a RP-HPLC system. GTEs at 150, 200, and 300 mg per 100 g of flour were formulated. The results obtained showed that green tea catechins were relatively stable in dough. The stability of (−)-EGCG and (−)-ECG was determined at an interval of every 2 min during baking. Their stability decreased as the baking progressed and increased as the concentration of GTE was increased in the biscuit dough. The stability of (−)-EGCG also increased as pH of the dough was reduced and made less alkaline.
Author: E.J. Okello and G.J. McDougall and S. Kumar and C.J. Seal
There is mounting evidence that the deposition and aggregation of β-amyloid peptides (Aβ) in the brain play a significant role in the development and pathogenesis of Alzheimer's disease. There is further evidence that free radical species such as hydrogen peroxide (H2O2) mediate Aβ induced toxicity. Previous studies have demonstrated that green tea polyphenols possess neuroprotective properties through their ability to ameliorate oxidative stress induced by free radical species. Green tea polyphenols have also been shown to enhance cognition in various animal models of induced cognitive impairment. Upon ingestion, green tea polyphenols are metabolised and undergo bio-transformation which affects their bioavailability and therefore efficacy. In this study, a green tea extract was subjected to a simulated gastrointestinal digestion and a ‘colon-available’ extract (CAGTE) prepared and assessed for its potential protective effects against H2O2 and Aβ(1–42) induced cytotoxicity using differentiated PC12 cells (dPC12) as a model for neuronal cells. CAGTE represents green tea phytochemicals potentially available after upper gastrointestinal digestion. CAGTE which was depleted in flavan-3-ols, as shown by LC–MS analysis, protected dPC12 cells at concentration ranges of 0.3–10 μg/ml and 0.03–0.125 μg/ml for H2O2 and Aβ(1–42), induced cytotoxicity, respectively. At high concentrations, CAGTE exhibited direct anti-proliferative effects, in line with the reputed anti-cancer properties of green tea polyphenols. These results demonstrate that potentially bioavailable green tea metabolites are able to ameliorate both H2O2 and Aβ(1–42) induced cytotoxicity.
Author: Chung S. Yang and Hong Wang and Guang Xun Li and Zhihong Yang and Fei Guan and Huanyu Jin
The cancer preventive activities of tea (Camellia sinensis Theaceae) have been studied extensively. Inhibition of tumorigenesis by green tea extracts and tea polyphenols has been demonstrated in different animal models, including those for cancers of the skin, lung, oral cavity, esophagus, stomach, small intestine, colon, bladder, liver, pancreas, prostate, and mammary glands. Many studies in cell lines have demonstrated the modulation of signal transduction and metabolic pathways by (−)-epigallocatechin-3-gallate (EGCG), the most abundant and active polyphenol in green tea. These molecular events can result in cellular changes, such as enhancement of apoptosis, suppression of cell proliferation, and inhibition of angiogenesis. Nevertheless, the molecular mechanisms of inhibition of carcinogenesis in animals and humans remain to be further investigated. Future research directions in this area are discussed.
Author: Jian-Min Yuan and Canlan Sun and Lesley M. Butler
Experimental studies have consistently shown the inhibitory activities of tea extracts on tumorigenesis in multiple model systems. Epidemiological studies, however, have produced inconclusive results in humans. A comprehensive review was conducted to assess the current knowledge on tea consumption and risk of cancers in humans. In general, consumption of black tea was not associated with lower risk of cancer. High intake of green tea was consistently associated with reduced risk of upper gastrointestinal tract cancers after sufficient control for confounders. Limited data support a protective effect of green tea on lung and hepatocellular carcinogenesis. Although observational studies do not support a beneficial role of tea intake on prostate cancer risk, phase II clinical trials have demonstrated an inhibitory effect of green tea extract against the progression of prostate pre-malignant lesions. Green tea may exert beneficial effects against mammary carcinogenesis in premenopausal women and recurrence of breast cancer. There is no sufficient evidence that supports a protective role of tea intake on the development of cancers of the colorectum, pancreas, urinary tract, glioma, lymphoma, and leukemia. Future prospective observational studies with biomarkers of exposure and phase III clinical trials are required to provide definitive evidence for the hypothesized beneficial effect of tea consumption on cancer formation in humans.
Author: Jonathan W. Betts and Stuart P. Kitney and Yiton Fu and Wei-Min Peng and Stephen M. Kelly and Stephen J. Haswell
Green tea catechins have been reported to have multiple health benefits. To understand their metabolic and toxicological interactions in the human body studies need to be undertaken using stable isotope labelled compounds, but they can be time consuming and expensive. Using microreactor technology labelling catechins could be produced more quickly and at a reduced cost. This research reports on a 2-step synthesis of deuterium labelled epicatechin developed using microreactor technology for the production.